China Resources Double-Crane Pharmaceutical Co.,Ltd.
Symbol: 600062.SS
SHH
23.35
CNYDzisiejsza cena rynkowa
17.5971
Wskaźnik P/E
-0.5329
Wskaźnik PEG
24.20B
Kapitalizacja MRK
- 0.01%
Rentowność DIV
China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062-SS) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 3457 | 2830.7 | 3637.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 240.7 | 200.5 | 803.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 2403.5 | 2362.8 | 2127 | ||||||||||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 1562.4 | 1878.6 | 1665.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 215.5 | 92.8 | 92.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 7638.5 | 7165 | 7522.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3852.5 | 3506.6 | 2957.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 906.1 | 935 | 788.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 2482.3 | 2281 | 1899.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 3388.3 | 3216 | 2687.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 403.1 | 149.8 | -500.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 192 | 124.7 | 73.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 22.1 | 320.6 | 935.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 7858 | 7317.6 | 6153.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 15496.5 | 14482.5 | 13676.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 696.7 | 744.5 | 847.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 432.9 | 32.1 | 29.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 65.7 | 201.7 | 138.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 29.9 | 232.9 | 35.4 | ||||||||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 180.6 | 198.8 | 153.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 1822.3 | 2042.3 | 57.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 364 | 741.1 | 468.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 29.9 | 32.9 | 35.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 3526.1 | 3752.9 | 3199.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 1039.7 | 1043.2 | 1043.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 9670.6 | 8560.9 | 8196.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 380 | 594.3 | 561.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | -175.7 | 103.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 11090.4 | 10022.6 | 9905.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 15496.5 | 14482.5 | 13676.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 699.4 | 707 | 571.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 11789.8 | 10729.6 | 10476.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||||||||||||||
Total Investments | 0 | 643.8 | 350.3 | 303.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 462.9 | 265 | 64.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | -2753.4 | -2365.3 | -2769.1 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 1333 | 1215.4 | 972.1 | ||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 655.5 | 540.6 | 465 | ||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -18.1 | -20.7 | -23.8 | ||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -1705.5 | 36 | 23.8 | ||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -412.6 | -413.5 | -143.5 | ||||||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -488.7 | -266.2 | -130.7 | ||||||||||||||||||||||||||
cash-flows.row.inventory | 0 | 315.7 | -34.3 | -384.5 | ||||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -221.6 | -92.2 | 395.5 | ||||||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -18 | -20.7 | -23.8 | ||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 1798.5 | -16.1 | 47.2 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -604.5 | -525.5 | -491.7 | ||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | -127.2 | -409.2 | 36.6 | ||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -2340 | -1350 | -3199.9 | ||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 2303 | 2951.7 | 3051.7 | ||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 60.9 | -0.2 | 33.4 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -707.8 | 666.8 | -569.8 | ||||||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -9.3 | -6.2 | -47.7 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | -29.7 | 144.7 | 0 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -1 | -290.9 | 0 | ||||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -300.5 | -801.8 | -302.6 | ||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -17.8 | -337 | -28.3 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -358.3 | -1291.2 | -378.6 | ||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 3.7 | 12.3 | 1.3 | ||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 585.8 | 729.6 | 393.8 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 3216.3 | 2614.7 | 1885.1 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 2630.4 | 1885.1 | 1491.3 | ||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 1650.8 | 1341.7 | 1340.9 | ||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -604.5 | -525.5 | -491.7 | ||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 1046.3 | 816.1 | 849.2 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 10089.3 | 9446.9 | 9111.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 4948.2 | 4231.8 | 4030 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 5141.2 | 5215.1 | 5081.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -14.5 | 639.7 | 612.8 | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 3684.5 | 3901.5 | 3978.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 8632.6 | 8133.4 | 8008.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 52.9 | 88.5 | 54.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 15.4 | 10.6 | 11.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 97.3 | 8.5 | -15.8 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -14.5 | 639.7 | 612.8 | ||||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 97.3 | 8.5 | -15.8 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 15.4 | 10.6 | 11.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 655.5 | 582.3 | 491 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 1456.7 | 1406.1 | 1136.9 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 1554 | 1414.6 | 1121.2 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 240.6 | 199.3 | 149.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 1333 | 1180.1 | 935.7 |
Często zadawane pytania
Ile wynosi China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) aktywów ogółem?
China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) całkowite aktywa to 15496483691.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.554.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 1.160.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.134.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.147.
Co to jest China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 1333029471.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 462877986.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 3684461873.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.